Rapid improvement of obsessive-compulsive disorder associated with schizophrenia with cariprazine add-on in a subject under paliperidone long-acting injection: a case report

  • Domenico De Berardis
  • , Federica Vellante
  • , Michele Fornaro
  • , Laura Orsolini
  • , Alessandro Valchera
  • , Gaia Baroni
  • , Yong Ku Kim
  • , Giovanni Martinotti
  • , Massimo Di Giannantonio

Research output: Contribution to journalArticlepeer-review

Abstract

Obsessive-compulsive disorder is often associated with schizophrenia and may represent a significant challenge in the treatment as this comorbidity may not respond properly to antipsychotic medication and usually require a pharmacological and psychotherapeutic add-on. In the present case report, we present the case of a 26-year-old male blue-collar subject who developed obsessive-compulsive disorder after a year of complete remission of schizophrenia symptoms under paliperidone long-acting injection that rapidly resolved after low-dosage cariprazine add-on. No adverse effects were reported due to cariprazine- paliperidone long-acting injection combination.

Original languageEnglish
Pages (from-to)113-118
Number of pages6
JournalInternational clinical psychopharmacology
Volume35
Issue number2
DOIs
Publication statusPublished - 2020 Mar 1

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Rapid improvement of obsessive-compulsive disorder associated with schizophrenia with cariprazine add-on in a subject under paliperidone long-acting injection: a case report'. Together they form a unique fingerprint.

Cite this